Voglibose
- Generic Name
- Voglibose
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H21NO7
- CAS Number
- 83480-29-9
- Unique Ingredient Identifier
- S77P977AG8
- Background
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
- Indication
For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.
- Associated Conditions
- Hyperglycemia, Postprandial, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
- Associated Therapies
- Glycemic Control
Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2018-08-22
- Target Recruit Count
- 3000
- Registration Number
- NCT00212017
- Locations
- 🇯🇵
National Cardiovascular Center, Suita, Osaka, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath